CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Abstract Methods that enable rapid, sensitive and specific analyses of nucleic acid sequences have positive effects on precise disease diagnostics and effective clinical treatments by providing direct insight into clinically relevant genetic information. Thus far, many CRISPR/Cas systems have been repurposed for diagnostic functions and are revolutionizing the accessibility of robust diagnostic tools due to their high flexibility, sensitivity and specificity. As RNA-guided targeted recognition effectors, Cas9 variants have been utilized for a variety of diagnostic applications, including biosensing assays, imaging assays and target enrichment for next-generation sequencing (NGS), thereby enabling the development of flexible and cost-effective tests. In addition, the ensuing discovery of Cas proteins (Cas12 and Cas13) with collateral cleavage activities has facilitated the development of numerous diagnostic tools for rapid and portable detection, and these tools have great potential for point-of-care settings. However, representative reviews proposed on this topic are mainly confined to classical biosensing applications; thus, a comprehensive and systematic description of this fast-developing field is required. In this review, based on the detection principle, we provide a detailed classification and comprehensive discussion of recent works that harness these CRISPR-based diagnostic tools from a new perspective. Furthermore, current challenges and future perspectives of CRISPR-based diagnostics are outlined.

[1]  Stephen A Bustin,et al.  Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. , 2005, Clinical science.

[2]  Lingwen Zeng,et al.  An ultrasensitive and specific point-of-care CRISPR/Cas12 based lateral flow biosensor for the rapid detection of nucleic acids. , 2020, Biosensors & bioelectronics.

[3]  Robert Tjian,et al.  CASFISH: CRISPR/Cas9-mediated in situ labeling of genomic loci in fixed cells , 2015, Proceedings of the National Academy of Sciences.

[4]  Albert J R Heck,et al.  Structural basis for CRISPR RNA-guided DNA recognition by Cascade , 2011, Nature Structural &Molecular Biology.

[5]  Jinming Li,et al.  RCasFISH: CRISPR/dCas9-mediated In Situ imaging of mRNA transcripts in fixed cells and tissues. , 2019, Analytical chemistry.

[6]  Robert H. Singer,et al.  Fluorescence in situ hybridization: past, present and future , 2003, Journal of Cell Science.

[7]  J. Keith Joung,et al.  TALENs: a widely applicable technology for targeted genome editing , 2012, Nature Reviews Molecular Cell Biology.

[8]  David A. Scott,et al.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells , 2014, Nature Biotechnology.

[9]  D. Dubnau,et al.  Noise in Gene Expression Determines Cell Fate in Bacillus subtilis , 2007, Science.

[10]  N. Neff,et al.  FLASH: a next-generation CRISPR diagnostic for multiplexed detection of antimicrobial resistance sequences , 2018, bioRxiv.

[11]  R. Pazdur,et al.  Next-Generation Sequencing in Oncology in the Era of Precision Medicine. , 2016, JAMA oncology.

[12]  Mazhar Adli,et al.  Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease , 2014, Nature Biotechnology.

[13]  C. Liu,et al.  Exploring the Trans-Cleavage Activity of CRISPR Cas12a (cpf1) for the Development of a Universal Electrochemical Biosensor. , 2019, Angewandte Chemie.

[14]  G. Urban,et al.  CRISPR/Cas13a powered electrochemical microfluidic biosensor for nucleic acid amplification-free miRNA diagnostics , 2019, bioRxiv.

[15]  G T Montelione,et al.  Human epidermal growth factor , 1990, FEBS letters.

[16]  Jennifer A. Doudna,et al.  CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity , 2018, Science.

[17]  Practice Bulletin No. 163: Screening for Fetal Aneuploidy , 2016, Obstetrics and gynecology.

[18]  Hayden C. Metsky,et al.  Field-deployable viral diagnostics using CRISPR-Cas13 , 2018, Science.

[19]  Richard Bruch,et al.  CRISPR/Cas13a‐Powered Electrochemical Microfluidic Biosensor for Nucleic Acid Amplification‐Free miRNA Diagnostics , 2019, Advanced materials.

[20]  Anne E Carpenter,et al.  Visualization of image data from cells to organisms , 2010, Nature Methods.

[21]  Marjolein Kriek,et al.  Next‐Generation Diagnostics: Gene Panel, Exome, or Whole Genome? , 2015, Human mutation.

[22]  Ting Yuan,et al.  A high fidelity CRISPR/Cas12a based lateral flow biosensor for the detection of HPV16 and HPV18 , 2020 .

[23]  Jennifer A. Doudna,et al.  Enhanced proofreading governs CRISPR-Cas9 targeting accuracy , 2017, Nature.

[24]  Lluis Montoliu,et al.  Genome Editing , 2018, Advances in Experimental Medicine and Biology.

[25]  Y. Ebenstein,et al.  Selective nanopore sequencing of human BRCA1 by Cas9-assisted targeting of chromosome segments (CATCH) , 2018, Nucleic acids research.

[26]  P. Marszalek,et al.  Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage , 2015, Nucleic acids research.

[27]  Da Xing,et al.  Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Triggered Isothermal Amplification for Site-Specific Nucleic Acid Detection. , 2018, Analytical chemistry.

[28]  Da Xing,et al.  High-Fidelity and Rapid Quantification of miRNA Combining crRNA Programmability and CRISPR/Cas13a trans-Cleavage Activity. , 2019, Analytical chemistry.

[29]  Emily H Turner,et al.  Target-enrichment strategies for next-generation sequencing , 2010, Nature Methods.

[30]  R. Mathies,et al.  Rapid and Fully Microfluidic Ebola Virus Detection with CRISPR-Cas13a. , 2019, ACS sensors.

[31]  Marilyn M. Li,et al.  Clinical utility of custom-designed NGS panel testing in pediatric tumors , 2019, Genome Medicine.

[32]  Ying Wang,et al.  RCA-assisted CRISPR/Cas9 cleavage (RACE) for highly specific detection of multiple extracellular vesicle microRNAs. , 2019, Analytical chemistry.

[33]  Matthew P. Goetz,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[34]  Scott A. Rifkin,et al.  Imaging individual mRNA molecules using multiple singly labeled probes , 2008, Nature Methods.

[35]  Aviv Regev,et al.  Nucleic acid detection with CRISPR-Cas13a/C2c2 , 2017, Science.

[36]  Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders , 2016, Obstetrics and gynecology.

[37]  David A. Scott,et al.  Rationally engineered Cas9 nucleases with improved specificity , 2015, Science.

[38]  Mandeep Sandhu,et al.  Detection of unamplified target genes via CRISPR–Cas9 immobilized on a graphene field-effect transistor , 2019, Nature Biomedical Engineering.

[39]  J. Keith Joung,et al.  731. High-Fidelity CRISPR-Cas9 Nucleases with No Detectable Genome-Wide Off-Target Effects , 2016 .

[40]  Qiu-Xiang Cheng,et al.  CRISPR-Cas12a-assisted nucleic acid detection , 2018, Cell Discovery.

[41]  Lyndon Gommersall,et al.  Basic principles of real-time quantitative PCR , 2005, Expert review of molecular diagnostics.

[42]  U. Landegren,et al.  Direct observation of individual endogenous protein complexes in situ by proximity ligation , 2006, Nature Methods.

[43]  P. Chu,et al.  A CRISPR–Cas9-triggered strand displacement amplification method for ultrasensitive DNA detection , 2018, Nature Communications.

[44]  Jennifer A. Doudna,et al.  Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection , 2016, Nature.

[45]  Sita J. Saunders,et al.  An updated evolutionary classification of CRISPR–Cas systems , 2015, Nature Reviews Microbiology.

[46]  Kira S. Makarova,et al.  Diversity and evolution of class 2 CRISPR–Cas systems , 2017, Nature Reviews Microbiology.

[47]  Huangxian Ju,et al.  MicroRNA: function, detection, and bioanalysis. , 2013, Chemical reviews.

[48]  Shiyuan Li,et al.  The CCTL (Cpf1-assisted Cutting and Taq DNA ligase-assisted Ligation) method for efficient editing of large DNA constructs in vitro , 2017, Nucleic acids research.

[49]  S. Rozelle,et al.  Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review , 2020, Infectious Diseases of Poverty.

[50]  Renato Martins,et al.  NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[51]  Luca Pinello,et al.  Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing , 2018, Nature Biotechnology.

[52]  Sung Jae Kim,et al.  dCas9-mediated Nanoelectrokinetic Direct Detection of Target Gene for Liquid Biopsy. , 2018, Nano letters.

[53]  Q. Ouyang,et al.  Paired Design of dCas9 as a Systematic Platform for the Detection of Featured Nucleic Acid Sequences in Pathogenic Strains. , 2017, ACS synthetic biology.

[54]  Benjamin P. Kleinstiver,et al.  Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants , 2020, Science.

[55]  Jin-Soo Kim,et al.  Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases , 2014, Genome research.

[56]  Charles A Gersbach,et al.  Increasing the specificity of CRISPR systems with engineered RNA secondary structures , 2019, Nature Biotechnology.

[57]  E. Crawford,et al.  Depletion of Abundant Sequences by Hybridization (DASH): using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications , 2015, bioRxiv.

[58]  N. Neff,et al.  FLASH: A next-generation CRISPR diagnostic for multiplexed detection of antimicrobial resistance sequences , 2018 .

[59]  Byungjin Hwang,et al.  CRISPR-Cap: multiplexed double-stranded DNA enrichment based on the CRISPR system , 2018, Nucleic acids research.

[60]  Adrian Pickar-Oliver,et al.  The next generation of CRISPR–Cas technologies and applications , 2019, Nature Reviews Molecular Cell Biology.

[61]  T. Stokłosa,et al.  Next Generation Sequencing in Oncology , 2016 .

[62]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[63]  Guozhen Liu,et al.  CRISPR/Cas Systems towards Next-Generation Biosensing. , 2019, Trends in biotechnology.

[64]  Jing Zhang,et al.  Comprehensive viral enrichment enables sensitive respiratory virus genomic identification and analysis by next generation sequencing , 2018, Genome research.

[65]  Eunji Kim,et al.  In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni , 2017, Nature Communications.

[66]  Eric S. Lander,et al.  C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector , 2016, Science.

[67]  T. Miethke,et al.  Development of a real-time PCR assay for rapid identification of methicillin-resistant Staphylococcus aureus from clinical samples. , 2005, International journal of medical microbiology : IJMM.

[68]  Shi-jia Ding,et al.  CRISPR/Cas12a-mediated Interfacial Cleaving of Hairpin DNA Reporter for Electrochemical Nucleic Acids Sensing. , 2020, ACS sensors.

[69]  Amy M. Sitapati,et al.  Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[70]  G. Church,et al.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.

[71]  P. Marszalek,et al.  Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage , 2015, Nucleic acids research.

[72]  J. Flanagan,et al.  RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. , 2012, The Journal of molecular diagnostics : JMD.

[73]  Qi Zhou,et al.  CDetection: CRISPR-Cas12b-based DNA detection with sub-attomolar sensitivity and single-base specificity , 2019, Genome Biology.

[74]  Henriette O'Geen,et al.  A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture , 2014, bioRxiv.

[75]  James J Collins,et al.  Precise Cas9 targeting enables genomic mutation prevention , 2016, Proceedings of the National Academy of Sciences.

[76]  R. Tjian,et al.  Dynamics of CRISPR-Cas9 genome interrogation in living cells , 2015, Science.

[77]  J. Jais,et al.  Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial , 2018, JAMA.

[78]  C. Thermes,et al.  Ten years of next-generation sequencing technology. , 2014, Trends in genetics : TIG.

[79]  L. Qin,et al.  CRISPR-Cas12a Coupled with Platinum Nano-Reporter for Visual Quantification of SNVs on a Volumetric Bar-Chart Chip. , 2019, Analytical chemistry.

[80]  Guillaume Lambert,et al.  Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components , 2016, Cell.

[81]  Feng Zhang,et al.  Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA , 2014, Cell.

[82]  Eun-Kyung Lim,et al.  A facile, rapid and sensitive detection of MRSA using a CRISPR-mediated DNA FISH method, antibody-like dCas9/sgRNA complex. , 2017, Biosensors & bioelectronics.

[83]  E. Rebar,et al.  Genome editing with engineered zinc finger nucleases , 2010, Nature Reviews Genetics.

[84]  Elizabeth K. Schmidt,et al.  Targeted genome fragmentation with CRISPR/Cas9 enables fast and efficient enrichment of small genomic regions and ultra-accurate sequencing with low DNA input (CRISPR-DS) , 2018, Genome research.

[85]  B. Ye,et al.  An RNA-Guided Cas9 Nickase-Based Method for Universal Isothermal DNA Amplification. , 2019, Angewandte Chemie.

[86]  Anthony M. Zador,et al.  Sources of PCR-induced distortions in high-throughput sequencing data sets , 2014, bioRxiv.

[87]  Noah Jakimo,et al.  Minimal PAM specificity of a highly similar SpCas9 ortholog , 2018, Science Advances.

[88]  G. Seelig,et al.  Dynamic DNA nanotechnology using strand-displacement reactions. , 2011, Nature chemistry.

[89]  Lv-yun Zhu,et al.  Highly Effective and Low-Cost MicroRNA Detection with CRISPR-Cas9. , 2018, ACS synthetic biology.

[90]  James J. Collins,et al.  Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 , 2018, Science.

[91]  Eli J. Fine,et al.  DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.

[92]  Luke A. Gilbert,et al.  Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.

[93]  Wei Li,et al.  Repurposing CRISPR-Cas12b for mammalian genome engineering , 2018, Cell Discovery.

[94]  David R. Liu,et al.  Evolved Cas9 variants with broad PAM compatibility and high DNA specificity , 2018, Nature.

[95]  Eric Samorodnitsky,et al.  Evaluation of Hybridization Capture Versus Amplicon‐Based Methods for Whole‐Exome Sequencing , 2015, Human mutation.

[96]  Jennifer A. Doudna,et al.  Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation , 2014, Science.

[97]  F S Fay,et al.  Visualization of single RNA transcripts in situ. , 1998, Science.

[98]  U. Landegren,et al.  Protein detection using proximity-dependent DNA ligation assays , 2002, Nature Biotechnology.

[99]  Jennifer A. Doudna,et al.  A Cas9–guide RNA complex preorganized for target DNA recognition , 2015, Science.

[100]  Jian Sun,et al.  Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-Mediated Lateral Flow Nucleic Acid Assay. , 2020, ACS nano.

[101]  U Landegren,et al.  Padlock probes: circularizing oligonucleotides for localized DNA detection. , 1994, Science.

[102]  J. Joung,et al.  High-fidelity CRISPR-Cas9 variants with undetectable genome-wide off-targets , 2015, Nature.

[103]  Martin J. Aryee,et al.  Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing , 2014, Nature Biotechnology.

[104]  Jeremy Stinson,et al.  CRISPR off-target analysis in genetically engineered rats and mice , 2018, Nature Methods.

[105]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[106]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[107]  Shiyuan Li,et al.  HOLMESv2: a CRISPR-Cas12b-assisted platform for nucleic acid detection and DNA methylation quantitation. , 2019, ACS synthetic biology.

[108]  Konstantin Severinov,et al.  Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3′-terminal segment of guide RNA , 2016, Nucleic acids research.

[109]  John M S Bartlett,et al.  Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[110]  L. Wilkins-Haug,et al.  Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening , 2018, Pediatric radiology.

[111]  P. Hsu,et al.  Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity. , 2016, Molecular cell.

[112]  John M S Bartlett,et al.  Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. , 2018, Archives of pathology & laboratory medicine.

[113]  David A. Scott,et al.  Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.

[114]  Jennifer A. Doudna,et al.  Programmed DNA destruction by miniature CRISPR-Cas14 enzymes , 2018, Science.

[115]  Xiaojun Ren,et al.  Direct Visualization of Single-Nucleotide Variation in mtDNA Using a CRISPR/Cas9-Mediated Proximity Ligation Assay. , 2018, Journal of the American Chemical Society.

[116]  R. Barrangou,et al.  Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria , 2012, Proceedings of the National Academy of Sciences.

[117]  R. Kanagal-Shamanna,et al.  Advances in clinical next-generation sequencing: target enrichment and sequencing technologies , 2016, Expert review of molecular diagnostics.